These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34430071)

  • 1. Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature.
    Dos Santos TJ; Rodrigues TC; Puñales M; Arrais RF; Kopacek C
    Curr Pediatr Rep; 2021; 9(4):142-153. PubMed ID: 34430071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.
    Kesavadev J; Srinivasan S; Saboo B; Krishna B M; Krishnan G
    Diabetes Ther; 2020 Jun; 11(6):1217-1235. PubMed ID: 32356245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children.
    Ferrito L; Passanisi S; Bonfanti R; Cherubini V; Minuto N; Schiaffini R; Scaramuzza A
    Minerva Pediatr (Torino); 2021 Dec; 73(6):474-485. PubMed ID: 34309344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated closed-loop control of diabetes: the artificial pancreas.
    Kovatchev B
    Bioelectron Med; 2018; 4():14. PubMed ID: 32232090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe.
    Janez A; Battelino T; Klupa T; Kocsis G; Kuricová M; Lalić N; Stoian AP; Prázný M; Rahelić D; Šoupal J; Tankova T; Zelinska N
    Diabetes Ther; 2021 Dec; 12(12):3107-3135. PubMed ID: 34694585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep.
    Cobry EC; Karami AJ; Meltzer LJ
    Curr Diab Rep; 2022 Jul; 22(7):283-290. PubMed ID: 35522354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers.
    Palmer W; Greeley SAW; Letourneau-Freiberg LR; Naylor RN
    J Diabetes Sci Technol; 2020 Sep; 14(5):860-867. PubMed ID: 32680447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023.
    Bassi M; Franzone D; Dufour F; Strati MF; Scalas M; Tantari G; Aloi C; Salina A; d'Annunzio G; Maghnie M; Minuto N
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol.
    de Bock M; McAuley SA; Abraham MB; Smith G; Nicholas J; Ambler GR; Cameron FJ; Fairchild JM; King BR; Geelhoed EA; Davis EA; O'Neal DN; Jones TW;
    BMJ Open; 2018 Aug; 8(8):e020275. PubMed ID: 30104309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to Uptake of Insulin Technologies and Novel Solutions.
    Pauley ME; Berget C; Messer LH; Forlenza GP
    Med Devices (Auckl); 2021; 14():339-354. PubMed ID: 34803408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.